‘Decoy’ Protein Works Against Multiple Coronavirus Variants in Early Study

By Anand on Tue, 01/Feb/2022 - 20:00 pm

The NIH continues to support the development of some very innovative therapies to control SARS-CoV-2, the coronavirus that causes COVID-19. One innovative idea involves a molecular decoy to thwart the coronavirus.

How’s that? The decoy is a specially engineered protein particle that mimics the 3D structure of the ACE2 receptor, a protein on the surface of our cells that the virus’s spike proteins bind to as the first step in causing an infection.

NIH GOV
Subscribe to